Conduit Pharmaceuticals Inc. • CDT

Capital at risk.

About Conduit Pharmaceuticals Inc.
Ticker
info
CDT
Trading on
info
NASDAQ
ISIN
info
US20678X2053
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. Andrew Regan
Headquarters
info
4581 Tamiami Trail North, Naples, FL, United States, 34103
Employees
info
6
Website
info
conduitpharma.com
Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has strategic services agreement with formulation development CDMO Agility Life Sciences to develop new solid oral-dosage form products. The company was founded in 2019 and is based in Naples, Florida.
Metrics
BasicAdvanced
Market cap
info
$6.1M
P/E ratio
info
-
EPS
info
-$20.53
Dividend Yield
info
0.00%
Beta
info
2.35
Forward P/E ratio
info
0
EBIDTA
info
$-15M
Ex dividend date
info
-
Price & volume
Market cap
info
$6.1M
Average daily volume
info
7M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
0
Earnings
EPS
info
-$20.53
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$-15M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
2.35
52-week High
info
$350.00
52-week Low
info
$0.51
50-day moving average
info
$0.86
200-day moving average
info
$8.46
Short ratio
info
0.24
Short %
info
17.24%
Management effectiveness
ROE (TTM)
info
0.00%
ROA (TTM)
info
168.82%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
11.3M
Float
info
6.5M
Insiders %
info
6.67%
Institutions %
info
0.79%
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.02
-
-
Q1 • 22Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$661M
$-2.4M
0.36%
Q4 • 24
$625M
$51.9M
8.31%
Q1 • 25
5.43%
2,258.65%
2,382.59%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$4.2M
$11M
262.01%
Q4 • 24
$3.21B
$1.98B
61.87%
Q1 • 25
76,361.26%
17,954.92%
76.39%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-3.8M
$0.1M
$4.2M
$-3.8M
Q4 • 24
$7.4M
-
$-96.8M
$-24.8M
Q1 • 25
295.15%
-
2,398.91%
549.38%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Conduit Pharmaceuticals Inc. share?
Collapse

Conduit Pharmaceuticals Inc. shares are currently traded for undefined per share.

How many shares does Conduit Pharmaceuticals Inc. have?
Collapse

Conduit Pharmaceuticals Inc. currently has 11.3M shares.

Does Conduit Pharmaceuticals Inc. pay dividends?
Collapse

No, Conduit Pharmaceuticals Inc. doesn't pay dividends.

What is Conduit Pharmaceuticals Inc. 52 week high?
Collapse

Conduit Pharmaceuticals Inc. 52 week high is $350.00.

What is Conduit Pharmaceuticals Inc. 52 week low?
Collapse

Conduit Pharmaceuticals Inc. 52 week low is $0.51.

What is the 200-day moving average of Conduit Pharmaceuticals Inc.?
Collapse

Conduit Pharmaceuticals Inc. 200-day moving average is $8.46.

Who is Conduit Pharmaceuticals Inc. CEO?
Collapse

The CEO of Conduit Pharmaceuticals Inc. is Dr. Andrew Regan.

How many employees Conduit Pharmaceuticals Inc. has?
Collapse

Conduit Pharmaceuticals Inc. has 6 employees.

What is the market cap of Conduit Pharmaceuticals Inc.?
Collapse

The market cap of Conduit Pharmaceuticals Inc. is $6.1M.

What is the P/E of Conduit Pharmaceuticals Inc.?
Collapse

The current P/E of Conduit Pharmaceuticals Inc. is null.

What is the EPS of Conduit Pharmaceuticals Inc.?
Collapse

The EPS of Conduit Pharmaceuticals Inc. is -$20.53.

What is the PEG Ratio of Conduit Pharmaceuticals Inc.?
Collapse

The PEG Ratio of Conduit Pharmaceuticals Inc. is null.